Supplementary Figure S1 from Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors

Autor:	Suzanne George, Jonathan A. Fletcher, Cloud P. Paweletz, Victor E. Velculescu, George D. Demetri, Andrew J. Wagner, Adrián Mariño-Enríquez, Olivia Triplett, Jillian Phallen, Constance M. Barysauskas, Jeffrey A. Morgan, Yanan Kuang, Alessandro Leal, César Serrano
Rok vydání:	2023
DOI:	10.1158/1078-0432.22475288.v1
Popis:	Sunitinib (A) and Regorafenib (B) plasma concentration (ng/mL) across several timepoints during cycle 1.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0979e821099c659660359bfe544ca411 https://doi.org/10.1158/1078-0432.22475288.v1 Zobrazit plný text záznamu